Medical Weight Loss for Anderson, Indiana Residents

Anderson, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Anderson through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Indiana, including Anderson: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Anderson Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Anderson, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Indiana for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

Medical weight loss for Anderson is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Think of our Costa Mesa clinic as your weight-loss provider even though you live in Anderson, because telehealth delivers the same physician-led program to Indiana without asking you to leave home. We care for patients throughout downtown Anderson and the greater Madison County area northeast of Indianapolis. Wherever you live in Indiana, your medication ships straight to your door in discreet packaging, so the same care reaches you whether you are in Anderson proper or one of the surrounding downtown Anderson and the greater Madison County area northeast of Indianapolis.

Your zip code inside Indiana does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Getting started in Anderson is simple: a Indiana licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Anderson choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Anderson

Here is what to expect, step by step, from anywhere in Anderson.

Step 1. Fill out a quick intake quiz about your weight, health history, and goals.

Step 2. Dr. Anjmun Sharma reviews your intake and meets you by secure video, usually within 48 hours, to decide whether compounded semaglutide or tirzepatide is right for you.

Step 3. If she prescribes, a state-licensed 503(a) pharmacy ships your medication to your Anderson address in cold-pack packaging.

Step 4. You keep going with video follow-ups, no office visit required, anywhere in .

Frequently Asked Questions, Anderson

Where is the New Hope Weight Loss location serving Anderson?

The location serving Anderson is our Costa Mesa, California clinic, which is our only physical site. We care for Anderson, Indiana patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Anderson patients?

It is the standard for Anderson. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Anderson in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Anderson patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Anderson patients.

What areas of Anderson do you serve?

We serve patients from across Anderson by telehealth, including downtown Anderson and the greater Madison County area northeast of Indianapolis.

What does treatment cost for Anderson patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Anderson.

Anderson Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Anderson, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.